Immunoprophylaxis - Defining Protective Antibody Function

Forthal, Donald N.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Small Research Grants (R03)
• Project #: 5R03AI044610-02
• Application #: 6170712
• Study Section: Special Emphasis Panel (ZRG5-AARR-2 (01))
• Program Officer: Gross, Michael
• Project Start: 1999-06-01
• Project End: 2002-05-31
• Budget Start: 2000-06-01
• Budget End: 2001-05-31
• Support Year: 2
• Fiscal Year: 2000
• Total Cost: $75,200

Institution

• Name: University of California Irvine
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 046705849
• City: Irvine
• State: CA
• Country: United States
• Zip Code: 92697

Publications

Forthal, D N; Landucci, G; Daar, E S (2001) Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. J Virol 75:6953-61

Forthal, D N; Landucci, G; Keenan, B (2001) Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count. AIDS Res Hum Retroviruses 17:553-61